Glimaday-P2 Tablet ER

Overview Glimaday-P2 Tablet ER

Extended-release Glimaday-P2 tablets are a dual-action medication designed to manage blood glucose. In adults with type 2 diabetes, this medication, used alongside diet and exercise, enhances blood sugar regulation by improving insulin effectiveness, thus reducing elevated glucose. Follow your physician's prescribed dosage and regimen meticulously. Ingestion with food mitigates potential stomach discomfort. For missed doses, take the medication promptly unless the next dose is imminent; in that case, omit the missed dose and resume the usual schedule. Never double the dose. Excessive intake may trigger hypoglycemia (low blood sugar). Concomitant use with other diabetes medications, alcohol consumption, or skipped meals elevates the risk of hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals require medical consultation before use. Kidney function tests will be performed before treatment commences. Limit alcohol consumption to minimize the probability of side effects.

Uses of Glimaday-P2 Tablet ER

Managing type 2 diabetes

Major Benefits of Glimaday-P2 Tablet ER:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or breaking it. Glimaday-P2 Extended-Release Tablets should be administered with a meal.

Common Side effects of Glimaday-P2 Tablet ER:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Glimaday-P2 Tablet ER:

Consume this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimaday-P2 Extended-Release Tablets should be administered with a meal.

How Glimaday-P2 Tablet ER works:

Glimaday-P2 ER tablets contain a triple-action antidiabetic formulation: glimepiride, metformin, and pioglitazone. These medications employ distinct methods to improve blood glucose management when single or dual-agent therapies prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release, thereby reducing blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin responsiveness. Pioglitazone, a thiazolidinedione, further amplifies insulin sensitivity.

What if you forget to take Glimaday-P2 Tablet ER :

Should you forget a Glimaday-P2 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.